{"id":"https://openalex.org/W2980240776","doi":"https://doi.org/10.1182/blood.v128.22.237.237","title":"Whole Exome Sequencing and Targeted Sequencing Reveal the Heterogeneity of Genomic Evolution and Mutational Profile in Smoldering Multiple Myeloma","display_name":"Whole Exome Sequencing and Targeted Sequencing Reveal the Heterogeneity of Genomic Evolution and Mutational Profile in Smoldering Multiple Myeloma","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2980240776","doi":"https://doi.org/10.1182/blood.v128.22.237.237","mag":"2980240776"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.237.237","doi":"https://doi.org/10.1182/blood.v128.22.237.237","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.237.237","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052819968","display_name":"Karma Ziad Salem","orcid":"https://orcid.org/0000-0002-0246-7785","observed_orcids":["https://orcid.org/0000-0002-0246-7785"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Karma Salem","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100392578","display_name":"Jihye Park","orcid":"https://orcid.org/0000-0002-4451-2046","observed_orcids":["https://orcid.org/0000-0002-4451-2046"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jihye Park","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061427755","display_name":"Claudia Freymond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I5124864","display_name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne","ror":"https://ror.org/02s376052","country_code":"CH","type":"education","lineage":["https://openalex.org/I2799323385","https://openalex.org/I5124864"]}],"countries":["CH","US"],"is_corresponding":true,"raw_author_name":"Claudia Freymond","raw_affiliation_strings":["Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland","Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland","institution_ids":["https://openalex.org/I5124864"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009037819","display_name":"Marzia Capelletti","orcid":"https://orcid.org/0000-0001-5095-7060","observed_orcids":["https://orcid.org/0000-0001-5095-7060","https://orcid.org/0009-0005-1654-5800"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marzia Capelletti","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025000402","display_name":"Daisy Huynh","orcid":"https://orcid.org/0000-0002-4633-4570","observed_orcids":["https://orcid.org/0000-0002-4633-4570"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daisy Huynh","raw_affiliation_strings":["Medical Oncology, Dana Farber Cancer Institute, Boston, MA","Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009466687","display_name":"Antonio Sacco","orcid":"https://orcid.org/0000-0003-2945-9416","observed_orcids":["https://orcid.org/0000-0003-2945-9416"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Sacco","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007419382","display_name":"Adriana Perilla-Glen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Adriana Perilla Glen","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000620040","display_name":"Aaron M. Caola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron M. Caola","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075607061","display_name":"Patrick M. Henrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Henrick","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039044023","display_name":"Eliezer M. Van Allen","orcid":"https://orcid.org/0000-0002-0201-4444","observed_orcids":["https://orcid.org/0000-0002-0201-4444"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Eliezer Van Allen","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100739514","display_name":"David Liu","orcid":"https://orcid.org/0000-0003-0346-5033","observed_orcids":["https://orcid.org/0000-0003-0346-5033"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David Liu","raw_affiliation_strings":["Medical Oncology, Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072050682","display_name":"Aldo Maria Roccaro","orcid":"https://orcid.org/0000-0002-1872-5128","observed_orcids":["https://orcid.org/0000-0002-1872-5128"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aldo M. Roccaro","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C Munshi","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001392592","display_name":"Gad A. Getz","orcid":"https://orcid.org/0000-0002-0936-0753","observed_orcids":["https://orcid.org/0000-0002-0936-0753"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gad Getz","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023152679","display_name":"Irene M. Ghobrial","orcid":"https://orcid.org/0000-0001-7361-3092","observed_orcids":["https://orcid.org/0000-0001-7361-3092"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene M. Ghobrial","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","Department of Medicine, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036677725","display_name":"Salomon Manier","orcid":"https://orcid.org/0000-0001-7653-711X","observed_orcids":["https://orcid.org/0000-0001-7653-711X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Salomon Manier","raw_affiliation_strings":["Hematology Department, Lille Hospital, Lille, France","Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Lille Hospital, Lille, France","institution_ids":["https://openalex.org/I3018718406"]},{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5001392592","https://openalex.org/A5007419382","https://openalex.org/A5039044023","https://openalex.org/A5052819968","https://openalex.org/A5061427755","https://openalex.org/A5100392578","https://openalex.org/A5100739514"],"corresponding_institution_ids":["https://openalex.org/I107606265","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I5124864"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.29776066,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"128","issue":"22","first_page":"237","last_page":"237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smoldering-multiple-myeloma","display_name":"smoldering multiple myeloma","score":0.996999979019165},{"id":"https://openalex.org/keywords/monoclonal-gammopathy-of-undetermined-significance","display_name":"monoclonal gammopathy of undetermined significance","score":0.9919999837875366},{"id":"https://openalex.org/keywords/multiple-myeloma-progression","display_name":"progression to multiple myeloma","score":0.828000009059906},{"id":"https://openalex.org/keywords/mutational-landscape","display_name":"mutational landscape","score":0.6690000295639038},{"id":"https://openalex.org/keywords/genomic-heterogeneity","display_name":"genomic heterogeneity","score":0.628000020980835},{"id":"https://openalex.org/keywords/myc-overexpression","display_name":"MYC overexpression","score":0.7799999713897705},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.6449999809265137},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9789999723434448},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.7039999961853027},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.5270000100135803},{"id":"https://openalex.org/keywords/subclonal-heterogeneity","display_name":"subclonal heterogeneity","score":0.546999990940094},{"id":"https://openalex.org/keywords/plasma-cells","display_name":"plasma cells","score":0.4099999964237213},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.39399999380111694},{"id":"https://openalex.org/keywords/oncogenes","display_name":"oncogenes","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C2777250017","wikidata":"https://www.wikidata.org/wiki/Q458138","display_name":"Monoclonal gammopathy of undetermined significance","level":5,"score":0.7818986177444458},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.780098557472229},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.6261759400367737},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.6086537837982178},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5814117193222046},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5120256543159485},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.49706366658210754},{"id":"https://openalex.org/C2776396001","wikidata":"https://www.wikidata.org/wiki/Q250694","display_name":"Plasma cell","level":3,"score":0.49241459369659424},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.4632716178894043},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.45757389068603516},{"id":"https://openalex.org/C113968399","wikidata":"https://www.wikidata.org/wiki/Q7559241","display_name":"Somatic evolution in cancer","level":3,"score":0.4149583578109741},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3684026002883911},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3542304039001465},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.340259313583374},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.329833447933197},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.3158899247646332},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2389521598815918},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2341785728931427},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.21104326844215393},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.20432314276695251},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1858867108821869},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.15970122814178467}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.237.237","doi":"https://doi.org/10.1182/blood.v128.22.237.237","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.237.237","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1989996736","https://openalex.org/W1997001746","https://openalex.org/W2077328896","https://openalex.org/W1687260518","https://openalex.org/W2409980816","https://openalex.org/W2882975044","https://openalex.org/W2131691150","https://openalex.org/W2067615548","https://openalex.org/W1484498617","https://openalex.org/W2466872276"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Recent":[2],"data":[3,336],"shows":[4],"that":[5,83,89,98,131,165,399,517,526,535,587],"multiple":[6],"myeloma":[7,501],"(MM)":[8],"almost":[9],"always":[10],"arises":[11],"from":[12,104,219,239,244,254,364,384,494,583],"precursor":[13],"states":[14],"called":[15],"Monoclonal":[16],"Gammopathy":[17],"of":[18,39,67,114,158,187,200,300,354,373,393,427,457,464,468,485,540,580,597],"Undetermined":[19],"Significance":[20],"(MGUS)":[21],"and":[22,71,95,139,151,161,269,278,303,319,349,390,413,441,470,537,568,595],"Smoldering":[23],"Multiple":[24],"Myeloma":[25],"(SMM),":[26],"but":[27],"not":[28,107,117],"all":[29],"patients":[30,43,220,240,408,497,505,542],"with":[31,221,241,251,312,370,518],"MGUS":[32,103,412],"or":[33],"SMM":[34,42,105,115,138,160,242,306,362,400,423,449,458,496,504,541],"develop":[35],"MM.":[36,141,417,480],"Risk":[37],"factors":[38,88,97],"progression":[40,188,202,528,582],"for":[41,591],"are":[44,106,148,409],"largely":[45],"based":[46],"on":[47,234,281,297,332],"tumor":[48],"load":[49,395],"as":[50,438,461,549,551],"represented":[51],"by":[52,321],"an":[53,324,371],"M-protein":[54],"\u2265":[55,72],"3":[56],"g/dL,":[57],"a":[58,292,403],"free":[59],"light":[60],"chain":[61],"(FLC)":[62],"ratio":[63],"outside":[64],"the":[65,77,80,86,96,100,111,169,185,428,474],"range":[66,392],"0.125":[68],"to":[69,189,205,271,323,366,411,416,500,514,576,585],"8,":[70],"10%":[73],"plasma":[74,248],"cells":[75,249],"in":[76,146,166,176,193,212,361,422,424,432,447,454,479,492,529,555],"BM.":[78],"However,":[79,184],"genetic":[81,524,578],"lesions":[82],"underlie":[84],"progression,":[85,94],"molecular":[87],"cause":[90,186],"rapid":[91],"versus":[92],"slow":[93],"distinguish":[99],"relatively":[101],"indolent":[102],"well":[108,118,550],"known.":[109],"Further,":[110,558],"genomic":[112,198],"landscape":[113],"is":[116,123,191,377,401],"characterized.":[119],"One":[120],"potential":[121,562],"factor":[122],"MYC":[124,132],"overexpression.":[125],"Bergsagel":[126],"et":[127],"al.":[128],"have":[129,203],"found":[130,510],"levels":[133],"increase":[134],"when":[135],"comparing":[136],"MGUS,":[137],"overt":[140,181],"Other":[142],"frequently":[143],"altered":[144],"pathways":[145],"MM":[147,162,182,190,381,433,545,556,586],"NF-kB,":[149],"MAPK":[150],"DNA":[152,253],"damage.":[153],"In":[154],"addition,":[155],"limited":[156],"studies":[157,199,386],"paired":[159],"samples":[163,218,238,299,397,493,520],"show":[164],"many":[167],"cases,":[168],"aggressive":[170],"subclones":[171],"can":[172,543,573],"already":[173],"be":[174,206,561,574],"detected,":[175],"small":[177],"cell":[178],"fractions,":[179],"before":[180],"develops.":[183],"unclear,":[192],"large":[194,389],"part":[195],"because":[196],"sequential":[197],"MGUS/SMM":[201,584],"yet":[204],"undertaken.":[207],"To":[208],"address":[209],"these":[210],"questions,":[211],"this":[213,571],"study":[214,533],"we":[215,509,521],"examine":[216],"clinically-annotated":[217],"SMM.":[222,530],"Methods:":[223],"We":[224,285,418],"performed":[225,287],"whole":[226,273],"exome":[227,274],"sequencing":[228,290,484,539],"(WES)":[229],"(mean":[230,488],"target":[231,328,489],"coverage":[232,490],"50X/100X)":[233],"49":[235],"germline-tumor":[236],"matched":[237,250],"(DNA":[243],"bone":[245],"marrow":[246],"CD138+":[247],"germline":[252],"peripheral":[255],"blood":[256],"mononuclear":[257],"cells).":[258],"Libraries":[259,308],"were":[260,309,337,445],"constructed":[261,311],"using":[262,291,339],"Agilent":[263,313],"SureSelect":[264,314],"XT2":[265,315],"library":[266,316],"prep":[267,317],"kit,":[268],"hybridized":[270],"Agilent's":[272],"V5+UTR":[275],"capture":[276],"probes":[277],"then":[279,330],"sequenced":[280,331],"HiSeq":[282,333],"2500":[283],"(Illumina).":[284],"also":[286,310,450],"targeted":[288,483,538],"deep":[289,482],"custom":[293],"enrichment":[294],"bait":[295],"set":[296],"25":[298],"progressor":[301],"(n=12)":[302],"non-progressor":[304],"(n=13)":[305],"samples.":[307],"kit":[318],"enriched":[320],"hybridizing":[322],"in-house":[325],"designed":[326],"customized":[327],"bait,":[329],"2500.":[334],"Sequencing":[335],"analyzed":[338],"previously":[340],"established":[341],"analytic":[342],"pipelines":[343],"including":[344,430],"MuTect,":[345],"RecapSeg,":[346],"GISTIC,":[347],"MutSig,":[348],"ABSOLUTE.":[350],"Results:":[351],"The":[352],"number":[353],"Somatic":[355],"Single":[356],"Nucleotide":[357],"Variants":[358],"(SSNVs)":[359],"seen":[360,478,554],"ranged":[363],"1":[365],"98":[367],"nonsilent":[368],"mutations":[369,431,512],"average":[372],"1.14":[374],"mutations/Mb,":[375],"which":[376,472],"slightly":[378],"lower":[379],"than":[380],"(1.6":[382],"mutations/Mb)":[383],"previous":[385],"(p-value=0.05).":[387],"This":[388,532],"varying":[391],"mutational":[394,564],"among":[396],"suggests":[398],"likely":[402,420],"heterogenous":[404],"entity":[405],"where":[406],"some":[407],"closer":[410,415],"others":[414],"identified":[419],"drivers":[421,579],"about":[425,455],"~32%":[426],"samples,":[429,459],"candidate":[434,546],"driver":[435,547],"genes":[436,487,548],"such":[437,460],"NRAS,":[439],"KRAS":[440],"PTPN11(overall":[442],"36":[443],"events":[444],"present":[446,589],"COSMIC).":[448],"had":[451],"somatic":[452],"CNAs":[453,553],"~50%":[456],"hyperdiploidy,":[462],"gain":[463],"chromosome":[465,476],"1q,":[466],"deletion":[467],"13p":[469],"17p,":[471],"match":[473],"hallmark":[475,552],"changes":[477],"Comparing":[481],"100":[486],"361X)":[491],"12":[495],"who":[498,506],"progressed":[499],"vs.":[502],"13":[503],"did":[507],"not,":[508],"non-synonymous":[511],"exclusive":[513],"progressors,":[515],"suggesting":[516],"more":[519],"may":[522,560,588],"find":[523],"alterations":[525],"predict":[527],"Conclusion:":[531],"demonstrates":[534],"WES":[536],"detect":[544],"patients.":[557],"there":[559],"different":[563],"features":[565],"between":[566],"progressors":[567],"non-progressors.":[569],"Thus,":[570],"approach":[572],"used":[575],"identify":[577],"clonal":[581],"opportunities":[590],"early":[592],"therapeutic":[593],"intervention":[594],"prevention":[596],"disease":[598],"progression.":[599],"Disclosures":[600],"Roccaro:":[601],"Takeda":[602],"Pharmaceutical":[603],"Company":[604],"Limited:":[605],"Honoraria.":[606],"Ghobrial:Takeda:":[607],"Honoraria;":[608,610,612,614],"Noxxon:":[609],"Amgen:":[611],"Novartis:":[613],"BMS:":[615],"Honoraria,":[616,620],"Research":[617,621],"Funding;":[618],"Celgene:":[619],"Funding.":[622]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}